908 Devices Inc. (NASDAQ:MASS) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp raised its holdings in shares of 908 Devices Inc. (NASDAQ:MASS) by 6.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 69,550 shares of the company’s stock after acquiring an additional 4,212 shares during the period. Bank of New York Mellon Corp owned approximately 0.20% of 908 Devices worth $358,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Iron Triangle Partners LP raised its holdings in shares of 908 Devices by 31.1% during the fourth quarter. Iron Triangle Partners LP now owns 1,284,947 shares of the company’s stock worth $14,417,000 after purchasing an additional 304,484 shares during the last quarter. Granahan Investment Management LLC lifted its holdings in shares of 908 Devices by 10.6% in the 4th quarter. Granahan Investment Management LLC now owns 2,038,658 shares of the company’s stock valued at $22,874,000 after buying an additional 195,368 shares during the period. Vanguard Group Inc. lifted its holdings in shares of 908 Devices by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 1,751,102 shares of the company’s stock valued at $13,221,000 after buying an additional 6,772 shares during the period. GAMMA Investing LLC purchased a new stake in shares of 908 Devices in the second quarter worth about $48,000. Finally, State Board of Administration of Florida Retirement System acquired a new stake in 908 Devices during the first quarter worth about $80,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

908 Devices Trading Down 5.2 %

Shares of MASS stock opened at $3.45 on Thursday. 908 Devices Inc. has a twelve month low of $3.42 and a twelve month high of $12.51. The stock has a market cap of $119.58 million, a P/E ratio of -3.22 and a beta of 0.98. The stock has a 50 day moving average of $4.31 and a 200 day moving average of $5.44.

908 Devices (NASDAQ:MASS) last posted its earnings results on Tuesday, August 6th. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.02. 908 Devices had a negative net margin of 72.10% and a negative return on equity of 22.47%. The firm had revenue of $14.05 million during the quarter, compared to analyst estimates of $13.69 million. On average, research analysts predict that 908 Devices Inc. will post -1.21 earnings per share for the current fiscal year.

908 Devices Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.